Final results of the multicenter randomized phase II PAZOGIST trial evaluating the efficacy of pazopanib (P) plus best supportive care (BSC) vs BSC alone in resistant unresectable metastatic and/or locally advanced gastrointestinal stromal tumors (GIST)

Affiliation auteurs!!!! Error affiliation !!!!
TitreFinal results of the multicenter randomized phase II PAZOGIST trial evaluating the efficacy of pazopanib (P) plus best supportive care (BSC) vs BSC alone in resistant unresectable metastatic and/or locally advanced gastrointestinal stromal tumors (GIST)
Type de publicationJournal Article
Year of Publication2015
AuteursBlay J-Y, Molimard M, Cropet C, Domont J, Toulmonde M, Bompas E, Cassier PAlexandre, Ray-Coquard ILaure, Rios M, Adenis A, Italiano A, Le Cesne A, Bouche O, Mir O, Duffaud F, Bertucci F, Isambert N, Belleville A, Gautier J, Perol D
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume33
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X